NVP-AUY922

【别名】 AUY-922

【CAS号】 747412-49-3

【纯度】 98%

【分子式】 C26H31N3O5

【分子量】 465.54

【简介】 NVP-AUY922 is an experimental drug candidate for the treatment of cancer.

NVP-AUY922 is an experimental drug candidate for the treatment of cancer. It was discovered through a collaboration between The Institute of Cancer Research and the pharmaceutical company Vernalis and licensed to Novartis. It is currently in Phase II clinical trials. NVP-AUY922 is an inhibitor of heat shock protein 90 (Hsp90), which is a chaperone protein that plays a role in the modification of a variety of proteins that have been implicated in oncogenesis. NVP-AUY922 has shown promising activity in preclinical testing against several different tumor types.